Novo Nordisk (CPH: NOVO-B) revenue
Novo Nordisk reported revenue of DKK 309,064m for fiscal 2025, 6.4% more than in fiscal 2024 (DKK 290,403m). Since fiscal 2019 its revenue has grown by 153.3%, an average growth of 16.8% a year.
Novo Nordisk has grown its revenue for 6 years in a row, and fiscal 2025 is the highest of its 7 fiscal years on record.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | DKK 309,064m | +6.4% | DKK 127,658m | 41.3% |
| 2024 | DKK 290,403m | +25.0% | DKK 128,339m | 44.2% |
| 2023 | DKK 232,261m | +31.3% | DKK 102,574m | 44.2% |
| 2022 | DKK 176,954m | +25.7% | DKK 74,809m | 42.3% |
| 2021 | DKK 140,800m | +10.9% | DKK 58,644m | 41.7% |
| 2020 | DKK 126,946m | +4.0% | DKK 54,126m | 42.6% |
| 2019 | DKK 122,021m | — | DKK 52,483m | 43.0% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of Danish kroner, except per-share amounts.
Novo Nordisk revenue compared with its sector
By revenue for its latest fiscal year, Novo Nordisk ranks 2nd of the 59 Spanish and European health care companies with a page on Celsmar. The sector median grew 4.5% in its latest fiscal year; Novo Nordisk, 6.4%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 1st | AstraZeneca | $58,739m | 8.6% |
| 2nd | Novo Nordisk | DKK 309,064m | 6.4% |
| 3rd | Philips | €17,834m | −1.0% |
| 4th | Haleon | £11,030m | −1.8% |
| 5th | Grifols | €7,524m | 4.3% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in health care stocks.
Questions about the revenue of Novo Nordisk
- How much revenue did Novo Nordisk make in fiscal 2025?
- Novo Nordisk reported revenue of DKK 309,064m for fiscal 2025, compared with DKK 290,403m in fiscal 2024.
- How much has the revenue of Novo Nordisk grown?
- Between fiscal 2019 and fiscal 2025 it went from DKK 122,021m to DKK 309,064m: 153.3% more, an average growth of 16.8% a year.
- What was the best year for revenue at Novo Nordisk?
- Of its last 7 fiscal years, fiscal 2025, with DKK 309,064m.
- Where does Novo Nordisk rank in its sector by revenue?
- It ranks 2nd of the 59 Spanish and European health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Novo Nordisk come from?
- From the report Novo Nordisk files every year in the European single electronic format (ESEF), the one it files with the regulator of its home market. Each fiscal year links to its filing.
Where each figure comes from
From the annual report Novo Nordisk files every year in the European single electronic format (ESEF). The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020. More on Novo Nordisk: the Novo Nordisk page · annual accounts · net income · dividends paid.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.